about
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancerOutcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation.Estimation of predictive accuracy in survival analysis using R and S-PLUS.Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients.Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups.Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimensAxillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-upSubtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trialGain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type statusSurvival prediction for terminally ill cancer patients: revision of the palliative prognostic score with incorporation of deliriumA new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysisLymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment.Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial.Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis.Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions.Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study.Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables.Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.The symptom interval in children and adolescents with soft tissue sarcomas.External validation of a multi-institutional retroperitoneal sarcoma nomogram.Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow TransplantaSecondary electrospray ionization-mass spectrometry and a novel statistical bioinformatic approach identifies a cancer-related profile in exhaled breath of breast cancer patients: a pilot study.Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.Long-term morbidity after multivisceral resection for retroperitoneal sarcoma.Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.The Changing Landscape of Intermediate- and Poor-Risk Germ Cell Tumors: Do We Need to Reclassify Patients With Metastatic Germ Cell Tumors?KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers.The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution.Prediction of survival in patients with thin melanoma: results from a multi-institution study.Persistent CD30 expression by embryonal carcinoma in the treatment time course: prognostic significance of a worthwhile target for personalized treatment.Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma.
P50
Q28238331-96F04DBC-F375-4454-89DD-AE528BB82434Q30607290-442930F8-40AA-45D1-AABF-89B19E32A950Q30650708-C7D28C7A-E46D-4504-9FA7-8410D5A8C7A1Q31025891-A1A681E2-F536-4894-802B-82380C123FCAQ33289347-E4C21B64-0850-4810-8B7A-5106B71A8663Q34042707-488F0F8F-C361-4044-8384-6A1091140EB9Q34154064-10B2E52D-FA0C-4CF1-805B-9FCA04CB302DQ34309960-70428649-6F66-4CDE-9FC9-E09082F19471Q34477281-ED15D20E-245A-411B-B8EC-FFBE395C9077Q34504614-05D6BF67-B52C-4CD6-AB96-F1745E4F797BQ34551964-CCD5EF52-DF21-455C-8A8C-4482B5B3E57BQ34806694-77C208B7-CCEB-40E8-BF72-7CB1B41C5E48Q35137474-1A43B08E-88B1-456E-B3D2-9403FC370E99Q35642409-AF79F605-B5B8-455F-95A5-E1AA90CFC183Q35766501-FF697A9D-FDDD-4FE4-B244-201622EF8C8EQ36344765-4DD5165D-ADD5-4142-991B-506B1595E227Q37087890-20CFD5FD-C3D9-48DD-8513-2F3B7E2AA9AAQ37724644-F153F283-537D-4D62-AA4B-620618F53091Q38444004-E38E52A3-1E3F-458B-A75C-52E25FE0B5D1Q38612831-BA39F511-8DB3-4A2F-A345-1E07B801B6DCQ38856807-FECEF63C-76DA-4802-8AF0-A8A6B302505FQ38865516-1C79DFEE-D805-4700-B9FF-9EC397DD8358Q38957054-0FAC5A88-9421-48EA-A86D-9ED1373D6FAFQ39386058-1DD166E6-C2F3-472D-82FC-9035567ABFEEQ39697683-D4041029-8739-44C1-995D-6092ED456C1FQ39858688-2516A098-FF82-4D5B-8BE2-62DAC2C2E2BBQ39934939-91FBD092-BCD8-4358-8737-E9790522D761Q39967615-04402843-587C-463F-B96B-44EFEA369964Q40237545-9562EA0E-34ED-4DA9-9807-E780A8B5BC5BQ40519108-BA3ED301-1DA5-4BC9-BC28-AB3159ECA4EEQ40539847-A43904A9-E2C1-448A-B867-A527C4C31164Q40871123-88E7AC20-96FC-40F0-9DBA-891BF1EF51B5Q41002971-585CA07C-8873-46AD-AC42-E0560F8E050FQ41432939-95A822D3-8497-4143-890D-FBE83DF2497CQ41741082-9B52B23E-3227-4EBF-8A80-613319C220CAQ43253773-93274323-2FAA-4684-887F-A57C3DC3DB17Q43413868-68D32295-5EFA-49F1-9BFD-AF466E98691DQ43703028-F55F9FF4-2BD5-4C4D-BDD8-431044498A5FQ43773181-3DE9A7FB-3F75-4732-8F5D-E215E22FDE07Q43854337-12C91842-2B95-4610-9684-4301C29B24B3
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rosalba Miceli
@ast
Rosalba Miceli
@en
Rosalba Miceli
@es
Rosalba Miceli
@nl
Rosalba Miceli
@sl
type
label
Rosalba Miceli
@ast
Rosalba Miceli
@en
Rosalba Miceli
@es
Rosalba Miceli
@nl
Rosalba Miceli
@sl
prefLabel
Rosalba Miceli
@ast
Rosalba Miceli
@en
Rosalba Miceli
@es
Rosalba Miceli
@nl
Rosalba Miceli
@sl
P1053
C-1215-2017
P106
P1153
7006273052
P21
P31
P3829
P496
0000-0003-0954-375X